nivolumab,regorafenib
bms,bayer
[]
tomorrow at asco #gi23, check out dr. james yu's poster #k10 on regorafenib and nivolumab in colorectal cancer. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. News and stories at https://t.co/XaP6iv4q19.